Immunotherapy for STI treatment: Agenus CEO on its genital herpes vaccine

Many companies are contending to hit the market first in the race for a genital herpes vaccine. The thread that ties them together? Immunotherapy – the wunderdrug for cancer therapy that’s now showing promise for infectious disease. But it hasn’t always been so, said Agenus CEO Garo Armen, whose immunotherapy approach in both cancer and in infectious disease […]

Race tight for genital herpes vaccine

After decades of stagnancy in the herpes therapeutics space, a real neck-and-neck race is emerging among three biotechs in the immunotherapy space: Genocea and Agenus, both based in Massachusetts, San Diego’s Vical are speeding ahead in developing a herpes vaccine. The idea for these companies is to develop a therapeutic vaccine targeted toward individuals who already have […]